This included SOX9 mutation (transcription factor involved in stem cell homeostasis), which was enriched in pre-cancerous lesions, whereas mutations in ARID1A (chromatin regulator), KRAS and TP53 were enriched in gastric cancers [115]. This evidence concerns the gene TP53 and gastric cancer.